Navigation Links
TRPM8 in Medical News

Role of Protein in the Development of Prostate Cancer Identified

...t studies have indicated that the protein known as trpm8 plays an important role in prostate cancer: high levels of trpm8 have been found in prostate carcinoma compared to normal prostate epithelial cells, and trpm8 has been suggested as a specific marker and therap...

Detecting Cold, Feeling Pain: Study Reveals Why Menthol Fresh

...tes how the body experiences intense stimuli temperature, in this case that can cause pain. As such, the receptor known as menthol receptor trpm8 -- provides a target for studying acute and chronic pain, as can result from inflammatory or nerve injury, the researchers say, and a potential new ta...

Menthol Receptor-A Thermosensitivity Determinant in Cold Temperature

...olves the mystery of how important the ion channel trpm8 is for alerting the body to cold temperatures.TRPM...d that isolated, cultured nerve cells that express trpm8 react to cooling stimuli, but cells cultured from mice lacking trpm8 do not. Also, mice engineered without...

Chronic pain can be cooled off !

...nt in the skin, which effectively transmits the cooling sensation. The scientists remarked: 'We have found that if you can selectively activate the trpm8 receptor, then you have a chance of suppressing other sensory inputs coming into the nervous system that are carrying pain information. We found a ver...
TRPM8 in Medical Technology

Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia

-- Data Presented at American Urological Association Annual Meeting -- SEATTLE and CHICAGO, April 28 /PRNewswire-FirstCall/ -- Researchers from Dendreon Corporation (Nasdaq: DNDN ) today presented preclinical data demonstrating the potential of D-3263, Dendreon's orally bioavailable small m...

Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer

SEATTLE, April 21 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN ) today announced that the Company has enrolled the first patient in a Phase 1 clinical trial of D3263 in patients with advanced cancer. D3263 is Dendreon's lead small molecule drug candidate designed to target TRPM8...

Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study

...immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington ...

Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial

...mmunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington...
TRPM8 in Biological News

Detecting cold, feeling pain: Study reveals why menthol feels fresh

...es how the body experiences intense stimuli – temperature, in this case – that can cause pain. As such, the receptor – known as menthol receptor trpm8 -- provides a target for studying acute and chronic pain, as can result from inflammatory or nerve injury, the researchers say, and a potential new ta...

Scripps research team sheds light on long-sought cold sensation gene

...ve withstood the test of genetics," he says. trpm8 was first discovered by Patapoutian’s group and pr...ould choose between two temperatures, mice without trpm8 showed essentially no preference in the temperatur...normal mice to flick their paw and lick them. trpm8 codes for an ion channel found at the tips of sens...

Novel method reveals how menthol discovery could point towards new or improved pain therapies

...utagenesis and high-throughput screening approach, the study assayed 14,000 trpm8 mutants to find mutants that were not enhanced by menthol but were otherwis...ur experiments yielded significant insights into the functional elements of trpm8 ion channel protein that would have been difficult to obtain using other mu...
TRPM8 in Biological Technology

Dendreon to Hold Conference Call on Tuesday, August 11, 2009 at 11:30 AM ET

...mmunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington ...

Dendreon Announces Webcast Presentations at Upcoming Investor Conferences

...mmunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington ...

Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacific Northwest

...immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington ...

Dendreon Announces Closing of Common Stock Offering

...mmunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington...

Dendreon Announces Common Stock Offering

...immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington ...

Dendreon Announces Webcast Presentations at Upcoming Investor Conferences

...mmunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington ...

Dendreon Reports First Quarter 2009 Financial Results

... announcing that D3263, a small molecule targeting trpm8 (a transmembrane cation channel protein), reduced ...acokinetics of orally-administered D3263 targeting trpm8 in patients with solid tumors that are refractory ...ng an orally-available small molecule that targets trpm8 that could be applicable to multiple types of canc...

Dendreon Announces Data Presentations and Webcast at AUA Annual Meeting

...:30 a.m. to 12:30 p.m. CDT - Abstract #1408: "Preclinical Evaluation of the trpm8 Ion Channel Agonist D-3263 for Benign Prostatic Hyperplasia." Poster prese...Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign pros...

Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer

...immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington ...

PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study

...immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington ...
TRPM8 in Biological Products

Rabbit Anti-TRPM8 Polyclonal Antibody, Unconjugated from Abcam

Description:... Rabbit polyclonal to trpm8 (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 79054 SwissProtID: Q3YFM7...
Company:Abcam
Other Tags
(Date:8/27/2015)... , ... August 27, 2015 , ... ... average annual cost to treat a patient with hemophilia is $175,000. Hemophilia is ... a cure and improving treatment. The RMHBDA exists to help raise funds for ...
(Date:8/27/2015)... CA (PRWEB) , ... August 27, 2015 , ... According ... and the American Heart Association have released new guidelines to educate doctors and patients ... last update to these particular guidelines came in 2007, so the new version is ...
(Date:8/27/2015)... ... August 27, 2015 , ... Allegheny General Hospital (AGH), part ... medical centers in the United States to receive international recognition for an advanced, ... Extracorporeal Life Support Organization (ELSO) , an international consortium of healthcare institutions dedicated ...
(Date:8/27/2015)... ... , ... About 10 percent of mothers experienced chronic, persistent ... more than 1,800 people, displacing hundreds of thousands and causing widespread damage estimated ... While most people don’t develop persistent depression after a major disaster like that, ...
(Date:8/27/2015)... Hills, CA (PRWEB) , ... August 27, 2015 ... ... Wearables & IoT Summit , scheduled for October 27-29, 2015 in San Jose, ... technology, the summit will primarily focus on the void that exists where battery ...
Breaking Medicine News(10 mins):Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 2Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 3Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 4Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 2Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 4Health News:About 10 Percent of Mothers Experienced Depression Two Years After Hurricane Katrina, New Study Shows 2Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2
(Date:8/12/2015)... 12, 2015   MedNet Solutions , an innovative ... of clinical research, is proud to announce that ... SaaS-based eClinical technology platform, has led the way to ... quarters of 2015.   Q2 2015 and Q1 2015 ... by contract value sold in the company,s 15 year ...
(Date:8/12/2015)... JOSE, Calif. , Aug. 12, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that ... recently announced Match-in-Sensor solution, have officially been named ... Alliance. As part of the certification, Synaptics, Natural ... FIDO 1.0 Universal Authentication Framework (UAF) standard and ...
(Date:8/10/2015)... 10, 2015 The latest 364 page ... analysis of the global border security market . ... $16.4bn in 2015. Now: Border security is hard ... of the business critical issue you need to know about ... ,s objective analysis of how this will impact your company ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 2Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 3Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 4Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 5Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 6Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 7Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 8Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 9
Other Contents